NetworkNewsBreaks

TuesdayFeb 21, 2023 11:36 am

NetworkNewsBreaks – SideChannel Inc. (SDCH) Announces Annual Meeting Results, Investor Day Highlights

SideChannel (OTCQB: SDCH), a provider of cybersecurity products and services to emerging, middle-market and enterprise companies, today announced the results of its annual meeting of stockholders and summarized highlights from its Investor Day broadcast, both of which occurred on Feb. 15, 2023. Results of the annual meeting included new board appointments, the ratified appointment of RBSM, LLP as the company’s independent auditor, and the granting of discretionary authority to the board of directors to combine outstanding shares of SideChannel’s common stock into a lesser number of outstanding shares, with the exact ratio to be determined by the board. During the…

Continue Reading

TuesdayFeb 21, 2023 11:31 am

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Secures Multiple Contracts for Processing Organics at Sea to Sky Soils

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) announced that its Sea to Sky Soils organic waste processing and composting facility has entered multiple contracts with a B.C. regional district for the processing of organic waste at the facility, which provides over 10,000 tonnes per annum. With a track record of operational excellence and sustainable practices, EverGen is one of the top regional processors of organics in B.C. The company’s commitment is to own and operate best-in-class facilities that offer its municipal and commercial partners both cost-effective and environmentally sustainable solutions for processing and recycling organics. “Contracts such as these de-risk our core…

Continue Reading

TuesdayFeb 21, 2023 11:16 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) to Interact with Leaders Pushing Boundaries of MS Research at Upcoming Forum

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders. The company today announced upcoming participation in the Americas Committee for Treatment and Research in Multiple Sclerosis (“ACTRIMS”) 2023 Forum taking place from Feb. 23-25 in San Diego, California, at the Marriott Marquis San Diego Marina. Founded in 1995, ACTRIMS is comprised exclusively of multiple sclerosis (“MS”) researchers and clinicians. “ACTRIMS provides us with an opportunity to interact with an esteemed community of leaders pushing the boundaries…

Continue Reading

TuesdayFeb 21, 2023 11:10 am

NetworkNewsBreaks – 121 Mining Investment Returns to Las Vegas on March 28-29, 2023

Building on the success of the inaugural 121 Mining Investment Las Vegas that was hosted last year, the upcoming two-day conference will facilitate the discovery of new mining projects, leverage unparalleled industry networks and enhance the investor education landscape. As the premier forum in the space, the event will focus on a series of thematic issues that are front and center to the mining industry, including energy transition, the gold outlook, precious metals investment strategies, uranium and the impacts of megatrends on metals and mining investing. For more information, visit https://www.weare121.com/121mininginvestment-las-vegas/ About 121 Group By hosting 121 Mining Investment events,…

Continue Reading

TuesdayFeb 21, 2023 10:57 am

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Builds on Growing Success with Sales of New K1 Call Boxes

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, sees continued growth through sales of 11 K1 Call Boxes to Larimer County, Colorado. The transaction was completed through KSCP resale partner Stream Speed Technologies (“SST”). Knightscope’s smallest emergency call box system, the K1 Call Box, offers one-touch connection with a ruggedized housing and simple interface. The call box offers a completely wireless solution for emergency phone calls and can also work with existing nearby wiring nearby. In addition, the system includes additional options that allow people who are deaf, hard of hearing or…

Continue Reading

TuesdayFeb 21, 2023 10:40 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report include the company closing the calendar year with nearly $11.5 million in cash and the completion of enrollment in the company’s phase 2 clinical trial in epidermolysis bullosa (“EB”). The report also noted that the company has seen advancement in its research using rare cannabinoids in the treatment of glaucoma and neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. “This…

Continue Reading

FridayFeb 17, 2023 2:59 pm

NetworkNewsBreaks – FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Initiates Testing on Green Ammonia Production System

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) today announced that it commenced system testing on its on-farm, containerized green ammonia production system. The company is testing its resilience to extreme outdoor weather conditions in anticipation of deployment in Manitoba, Canada. Per the update, the fully climatized containerized modules continue to operate efficiently under winter conditions. “FuelPositive has successfully built our containerized modules as fully climatized systems, capable of working in extreme temperatures, ranging from minus 50 C to plus 45 C. The units are temperature controlled and built to the strictest hazardous area classifications with redundant monitoring. Our systems are engineered to run without…

Continue Reading

FridayFeb 17, 2023 12:56 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD Demonstrates ~1,900% Better Permeability Through Skin

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its 28th granted patent worldwide and the first granted patent from its sixth patent family, titled Transdermal And/or Dermal Delivery of Lipophilic Active Agents. “The Canadian patent #3,093,414 is for improved compositions and methods for transdermal and dermal delivery of cannabinoids, including cannabidiol (‘CBD’) and tetrahydrocannabinol (‘THC’), all established on the company’s patented DehydraTECH technology,” a recent article reads. “In Lexaria’s 2018 study, DehydraTECH-CBD demonstrated almost a 1,900% increase in CBD permeability through human skin compared to a control formulation that was devoid of any commercial…

Continue Reading

FridayFeb 17, 2023 12:42 pm

NetworkNewsBreaks – McEwen Mining Inc.’s (NYSE: MUX) (TSX: MUX) Subsidiary Poised to Potentially Become World’s Next Copper Unicorn

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas with large exposure to copper through its 68%-owned subsidiary McEwen Copper. The company recently reported rich copper values over attractive widths, resulting from infill drilling at its Los Azules project. “Located in San Juan, Argentina, Los Azules is a large porphyry copper-gold-silver deposit expressing great potential, with ultimate depth and lateral extents yet to be fully determined… McEwen Copper resumed its drilling program in October 2022. It is designed to increase drill hole density and upgrade the copper resource classification to better understand…

Continue Reading

FridayFeb 17, 2023 12:29 pm

NetworkNewsBreaks – Psycheceutical Bioscience Inc. (BWVI) Inks Agreement for First-Ever Clinical Trials of a Proprietary Ketamine Topical Cream to Treat PTSD

Psycheceutical Bioscience (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for the next generation of mental health treatments, has entered into an exclusive agreement with iNGENū Pty Ltd., an Australian-based contract research organization. The agreement calls for iNGENū to conduct ​two human ​clinical trials of BWVI’s patented NeuroDirect(TM) ketamine topical ​in Australia. The first, a phase 1 trial, is designed to study 20 people and evaluate the safety, tolerability and pharmacokinetics of a single dose of NeuroDirect ketamine; the second, a phase 2 trial, is designed to study 115 participants diagnosed with post-traumatic stress disorder (“PTSD”) to evaluate the effectiveness…

Continue Reading